00378-7734 Ondansetron

Product NDC:

00378-7734

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 8.0

Unit: mg/1

Packages:

Code: 00378-7734-05

Description:

Effective Date: June 25, 2007

Discontinued: Oct. 9, 2014

Code: 00378-7734-93

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0378-7734-93)

Effective Date: June 25, 2007

Discontinued: May 31, 2024

Code: 00378-7734-97

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0378-7734-97)

Effective Date: June 25, 2007

Discontinued: May 31, 2024

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox